Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
- DOI
- 10.1016/j.eururo.2026.01.031
- Published
- 2026 May
- Container
- European urology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.eururo.2026.01.031,
title = {Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.},
author = {Bancroft EK and Page EC and McHugh J and Thomas S and Taylor N and Pope J and Evans DG and Rothwell J and Grindedal EM and Maehle L and James P and McKinley J and Mascarenhas L and Side L and Thomas T and van Leerdam ME and van Asperen CJ and Kiemeney LALM and Ringelberg J and Vlaming M and Rønlund K and Osther PJS and Helfand BT and Hutten CG and Oldenburg RA and Cybulski C and Wokolorczyk D and Ong KR and Huber C and Salinas M and Feliubadaló L and Oosterwijk JC and van Zelst-Stams WAG and Cook J and Rosario DJ and Maxwell K and Powers J and Buys S and Lyman J and Ausems MGEM and Schmutzler RK and Rhiem K and Izatt L and Tripathi V and Teixeira MR and Cardoso M and Foulkes WD and Aprikian A and Davidson R and Longmuir M and Ruijs MWG and Blom EW and van Engelen K and Williams R and Andrews L and Murphy DG and Saya S and Halliday D and Walker L and Liljegren A and Carlsson S and Azzabi A and Jobson I and Snape K and Gowie M and Harris M and Tischkowitz M and Taylor A and Kirk J and Susman R and Chen-Shtoyerman R and Spigelman A and Pachter N and Ahmed M and Cajal TRY and Krajc M and Cleaver R and Cruellas M and Perez-Ballestero E and Brady AF and Gallagher D and Donaldson A and Barwell J and Nicolai N and Friedman E and Hall MJ and Greenhalgh L and Murthy V and Copakova L and McGrath JS and Cooke P and Arun B and Myhill K and Hogben M and Hussain S and Aaronson NK and Ardern-Jones A and Bangma CH and Castro E and Dearnaley D and Eccles DM and Tricker K and Falconer A and Gronberg H and Hamdy FC and Khoo V and Lilja H and Lindeman GJ and Lubinski J and Axcrona K and Mikropoulos C and Mitra A and Offman J and Rennert G and Suri M and Dudderidge T and IMPACT Study Collaborators and Brook MN and Kote-Jarai Z and Eeles RA},
year = {2026},
journal = {European urology},
doi = {10.1016/j.eururo.2026.01.031},
url = {https://doi.org/10.1016/j.eururo.2026.01.031}
}RIS
TY - JOUR TI - Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study. AU - Bancroft EK AU - Page EC AU - McHugh J AU - Thomas S AU - Taylor N AU - Pope J AU - Evans DG AU - Rothwell J AU - Grindedal EM AU - Maehle L AU - James P AU - McKinley J AU - Mascarenhas L AU - Side L AU - Thomas T AU - van Leerdam ME AU - van Asperen CJ AU - Kiemeney LALM AU - Ringelberg J AU - Vlaming M AU - Rønlund K AU - Osther PJS AU - Helfand BT AU - Hutten CG AU - Oldenburg RA AU - Cybulski C AU - Wokolorczyk D AU - Ong KR AU - Huber C AU - Salinas M AU - Feliubadaló L AU - Oosterwijk JC AU - van Zelst-Stams WAG AU - Cook J AU - Rosario DJ AU - Maxwell K AU - Powers J AU - Buys S AU - Lyman J AU - Ausems MGEM AU - Schmutzler RK AU - Rhiem K AU - Izatt L AU - Tripathi V AU - Teixeira MR AU - Cardoso M AU - Foulkes WD AU - Aprikian A AU - Davidson R AU - Longmuir M AU - Ruijs MWG AU - Blom EW AU - van Engelen K AU - Williams R AU - Andrews L AU - Murphy DG AU - Saya S AU - Halliday D AU - Walker L AU - Liljegren A AU - Carlsson S AU - Azzabi A AU - Jobson I AU - Snape K AU - Gowie M AU - Harris M AU - Tischkowitz M AU - Taylor A AU - Kirk J AU - Susman R AU - Chen-Shtoyerman R AU - Spigelman A AU - Pachter N AU - Ahmed M AU - Cajal TRY AU - Krajc M AU - Cleaver R AU - Cruellas M AU - Perez-Ballestero E AU - Brady AF AU - Gallagher D AU - Donaldson A AU - Barwell J AU - Nicolai N AU - Friedman E AU - Hall MJ AU - Greenhalgh L AU - Murthy V AU - Copakova L AU - McGrath JS AU - Cooke P AU - Arun B AU - Myhill K AU - Hogben M AU - Hussain S AU - Aaronson NK AU - Ardern-Jones A AU - Bangma CH AU - Castro E AU - Dearnaley D AU - Eccles DM AU - Tricker K AU - Falconer A AU - Gronberg H AU - Hamdy FC AU - Khoo V AU - Lilja H AU - Lindeman GJ AU - Lubinski J AU - Axcrona K AU - Mikropoulos C AU - Mitra A AU - Offman J AU - Rennert G AU - Suri M AU - Dudderidge T AU - IMPACT Study Collaborators AU - Brook MN AU - Kote-Jarai Z AU - Eeles RA PY - 2026 JO - European urology DO - 10.1016/j.eururo.2026.01.031 UR - https://doi.org/10.1016/j.eururo.2026.01.031 ER -
APA
EK, B., EC, P., J, M., S, T., N, T., J, P., DG, E., J, R., EM, G., L, M., P, J., J, M., L, M., L, S., T, T., ME, V. L., CJ, V. A., LALM, K., J, R., M, V., K, R., PJS, O., BT, H., CG, H., RA, O., C, C., D, W., KR, O., C, H., M, S., L, F., JC, O., WAG, V. Z., J, C., DJ, R., K, M., J, P., S, B., J, L., MGEM, A., RK, S., K, R., L, I., V, T., MR, T., M, C., WD, F., A, A., R, D., M, L., MWG, R., EW, B., K, V. E., R, W., L, A., DG, M., S, S., D, H., L, W., A, L., S, C., A, A., I, J., K, S., M, G., M, H., M, T., A, T., J, K., R, S., R, C., A, S., N, P., M, A., TRY, C., M, K., R, C., M, C., E, P., AF, B., D, G., A, D., J, B., N, N., E, F., MJ, H., L, G., V, M., L, C., JS, M., P, C., B, A., K, M., M, H., S, H., NK, A., A, A., CH, B., E, C., D, D., DM, E., K, T., A, F., H, G., FC, H., V, K., H, L., GJ, L., J, L., K, A., C, M., A, M., J, O., G, R., M, S., T, D., Collaborators, I. S., MN, B., Z, K., & RA, E. (2026). Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.. European urology. https://doi.org/10.1016/j.eururo.2026.01.031
Source records
- pubmed · retrieved 2026-09-26T12:30:03.408Z
- europe-pmc · retrieved 2026-09-26T12:30:03.399Z